Mark S. Forman

Mark S. Forman has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Ventyx Biosciences, Inc. and Passage BIO, Inc. Over a trading history stretching from 31 December 2023 to 4 March 2026, the count stands at 5 filings.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

On 4 March 2026 came the latest disclosure, a transaction in Ventyx Biosciences, Inc. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.